Disposable Endoscopes Market Size, Share & Trends Analysis Report By Application (Bronchoscopy, ENT Endoscopy), By End-use (Hospitals, Clinics), By Region (Europe, North America, APAC), And Segment Forecasts, 2022 - 2030

Report Overview

The global disposable endoscopes market size was valued at USD 1.7 billion in 2021 and is expected to expand at a compound annual growth rate (CAGR) of 17.0% from 2022 to 2030. The growing cross-contamination issue of reusable endoscopes is one of the major factors expected to drive market growth. In 2020, Mr. Brian Dunkin MD, CMO of Boston Scientific Endoscopy stated that one in 20 patients has a pathogen contamination concern. Moreover, several tedious sterilization steps to eliminate all kinds of microorganisms from the reusable endoscopes are also expected to increase the adoption of disposable endoscopes.

For instance, according to Boston Scientific, cleaning of endoscopes during ERCP procedures requires over 100 series of manual steps to reuse and it’s also vulnerable to error. Furthermore, the increasing preference of medical professionals to use single-use or disposable endoscopic devices is supporting the market growth. For instance, The Centers for Medicare & Medicaid Services (CMS) 2020 has released a new device passcode for single-use endoscopes. Hospitals and Ambulatory Surgical Centers (ASCs) use this code for treating Medicare patients in the U.S. using single-use duodenoscopes.

A moderate impact has been observed during the COVID-19 outbreak on the disposable endoscope market growth. The decrease in the number of surgical procedures due to the COVID-19 pandemic also hampered product adoption. In addition, the shortage of medical staff due to the increased infection risks associated with the cleaning of endoscopes also increase the adoption of single-use devices during the COVID-19 pandemic. For instance, according to a study reported in the Journal of Bronchology & Interventional Pulmonology in 2021, in the U.S., about 11% of health workers were infected with COVID-19 and in Italy, the percentage is approximately 20%.

However, the demand for single-use endoscopes is expected to increase with the gradual depart of COVID-19 due to its safety and elimination of the possibilities of infection. Furthermore, single-use devices are more cost-effective than reusable ones, which is expected to drive market growth. For instance, according to the data published by the Association of Anesthetics in November 2019, the mean cost per patient for reusable flexible bronchoscopes is £511.00 with an associated risk of infection of 2.8%. The estimated mean cost of single-use flexible bronchoscopes per patient is £220.00 and a 0% risk of infection.

Similarly, in 2019, a study published in Chest Journal reported that reusable bronchoscopes used by hospitals are paying about 21% to 155% more per instrument as compared to disposable endoscopes. Consequently, the cost-effectiveness, lower chances of cross-contamination, and minimum resource utilization are in turn expected to propel the market growth over the forecast years. Rapid technological advancements coupled with the growing investments by key manufacturers to develop new, innovative products are anticipated to drive the market further. For instance, in May 2020, Ambu A/S, a single-use endoscope manufacturer, launched Ambu aView 2 Advance, a display unit for single-use endoscopes.

COVID19 disposable endoscopes market impact: 3.2% decrease in revenue growth from 2019 to 2020

This product is a mobile platform and can be used in different types of endoscopic devices including rhinolaryngoscope, bronchoscope, and cystoscopes among others. Omnivision, in November 2020, introduced imaging subsystems including image signal processor boards, camera modules, and cables for disposable endoscopic devices. Moreover, in November 2020, Olympus Corporation made partnerships with Ruhof Corporation and launched single-use procedure kits and hybrid tubing for endoscopes to reduce infection risks. Thus, the development of visualization systems and components for re-usable endoscopes is supporting the market growth.

Application Insights

The bronchoscopy segment accounted for the highest revenue share of more than 29% in 2021. The growing prevalence of lung disorders and high adoption of minimally invasive bronchoscope procedures are driving the segment growth. As per the American Lung Association, the recorded lung cancer cases in 2018 were 2.0 million, globally. Moreover, asthma, COPD, acute lower respiratory tract infections, lung cancer, and tuberculosis are other most common causes of severe acute illnesses and deaths globally. According to the World Health Organization (WHO), in 2017, about 334 million people were suffering from asthma globally and about 65 million people were suffering from moderate to severe COPD.

However, the fastest growth is expected from the ENT endoscopy application segment over the forecast years. The growth is attributed to the reduction of cross-contamination and costs associated with disposable endoscopes ENT service & cleaning and its growing adoption. In addition, the increasing prevalence of nose, ear, and throat infections is expected to propel segment growth. Furthermore, advancements in technology and subsequent product launches are supporting the fastest growth of this segment. For instance, in June 2020, 3NT Medical introduced a single-use ENT endoscope “Colibri Micro ENT Scope” in the U.S.

End-use Insights

The hospitals' end-user segment accounted for the highest revenue share of more than 47% in 2021 owing to favorable reimbursement policies and high product preference in hospitals for patients undergoing endoscopic procedures. Moreover, the presence of a large number of hospitals performing endoscopic procedures in developed and developing countries is propelling the segment growth. Growing awareness regarding infection risks associated with reusable endoscopic devices is also expected to boost the adoption of disposable devices in hospitals, thereby contributing to the segment growth.

On the other hand, the clinics' end-use segment is anticipated to witness the fastest growth rate over the forecast years. This growth can be credited to the high preference for disposable endoscopes in clinics on account of their cost-effectiveness. In addition, they pose a low risk of cross-contamination and offer a quick recovery time & minimal procedure time than the reusable endoscopes. Furthermore, the growing trend of same-day surgery in developed countries is expected to help augment the product adoption in clinics, thereby supporting overall market growth over the forecast perio0d.

Regional Insights

North America dominated the global market and accounted for the highest revenue share of more than 41.5% in 2021. It is attributed to the high adoption of advanced technologies, the presence of developed infrastructure, and growing awareness about minimally invasive surgeries. The increasing prevalence of cancer, gastrointestinal disorders, and the growing geriatric population are further expected to drive the regional market. According to the National Cancer Institute’s data, in 2020, the number of new cancer cases diagnosed was about 1,806,590 in the U.S. Furthermore, according to the Centers for Disease Control and Prevention (CDC), about 2.4 million people visited physician’s offices for digestive system disorders in the U.S.

In addition, increasing regulatory approvals by the regulatory authorities in this region to use endoscopes will drive market growth. For instance, Ambu aScope Cysto, a single-use flexible endoscope, received U.S. FDA 510k clearance in April 2020. However, Asia Pacific is estimated to register the fastest growth rate over the forecast years. Improving healthcare infrastructure and lenient regulatory frameworks are the major factors anticipated to drive the market in this region. In addition, rising chronic diseases burden and increasing awareness about the advantages of minimally invasive surgeries are expected to accelerate the product demand in the region. Highly populated countries, such as China and India, provide a large target patient pool, which is also anticipated to boost the regional market growth.

Key Companies & Market Share Insights

Key manufacturers are focusing on adopting key business strategies, such as collaboration, acquisition, and new product launches, to increase their product portfolio and hold a strong position in the market. In 2021, Ambu introduced its 3 new disposable endoscopes, Ambu aScope colonoscope, Duodeno, and gastroscope. In February 2019, Zsquare, an Israeli endoscopy firm, received USD 10 million for the development of a single-use endoscopic platform multiply.

It comprises a single-use, flexible, high-resolution, and ultrathin endoscope that improves usability and facilitates access to unserved indications during the diagnosis of common indications. Furthermore, Boston Scientific Corp. in December 2019, introduced single-use Duodenoscope “EXALT Model D” for ERCP (endoscopic retrograde cholangiopancreatography) procedures. Some of the prominent players in the global disposable endoscopes market include:

• Ambu A/S

• Prosurg Inc. (Neoscape, Inc.)

• AirStrip Technologies

• Boston Scientific Corp.

• Parburch Medical

• OBP Medical Corp.

• Welch Allyn (Hill-Rom Services Inc.)

• Allscripts Healthcare Solutions

• Flexicare Medical Ltd.

• Timesco Healthcare Ltd.

• Sunmed

Disposable Endoscopes Market Report Scope

Segments Covered in the Report

This report forecasts revenue growth at global, regional, and country levels and provides an analysis of the latest industry trends in each of the sub-segments from 2014 to 2028. For the purpose of this study, Grand View Research, Inc. has segmented the global disposable endoscopes market report based on application, end-use, and region:

• Application Outlook (Revenue, USD Million, 2014 - 2030)

  • Bronchoscopy

  • Urologic endoscopy

  • Arthroscopy

  • GI endoscopy

  • ENT endoscopy

  • Others

• End-use Outlook (Revenue, USD Million, 2014 - 2030)

  • Hospitals

  • Clinics

  • Diagnostics Centers

• Regional Outlook (Revenue, USD Million, 2014 - 2030)

  • North America

    • U.S.

    • Canada

  • Europe

    • U.K.

    • Germany

    • France

    • Italy

    • Spain

    • Russia

    • Switzerland

    • Denmark

  • Asia Pacific

    • Japan

    • China

    • India

    • Australia

    • Thailand

    • New Zealand

    • Indonesia

    • Malaysia

    • Vietnam

    • Philippines

  • Latin America

    • Mexico

    • Brazil

    • Argentina

  • Middle East & Africa

    • South Africa

    • Saudi Arabia

    • UAE

    • Kuwait

    • Israel

    • Qatar